BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28479028)

  • 1. Determination of predictors of severity for recipient adverse reactions during platelet product transfusions.
    Sut C; Tariket S; Cognasse F; Garraud O
    Transfus Clin Biol; 2017 Jun; 24(2):87-91. PubMed ID: 28479028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines and related molecules, and adverse reactions related to platelet concentrate transfusions.
    Cognasse F; Garraud O
    Transfus Clin Biol; 2019 Sep; 26(3):144-146. PubMed ID: 31327557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of donor- and recipient-associated factors to allergic transfusion reactions to platelets.
    Zheng Y; Pei D; Sweat L; Ryan M; Mestemacher MA; Gann M; Cheng C; Geiger TL
    Transfusion; 2021 Mar; 61(3):744-753. PubMed ID: 33314235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
    Josephson CD; Castillejo MI; Grima K; Hillyer CD
    Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet transfusions.
    Stroncek DF; Rebulla P
    Lancet; 2007 Aug; 370(9585):427-38. PubMed ID: 17679020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the plasma from platelet concentrates in transfusion reactions.
    Heddle NM; Klama L; Singer J; Richards C; Fedak P; Walker I; Kelton JG
    N Engl J Med; 1994 Sep; 331(10):625-8. PubMed ID: 8052271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scratching the surface of allergic transfusion reactions.
    Savage WJ; Tobian AA; Savage JH; Wood RA; Schroeder JT; Ness PM
    Transfusion; 2013 Jun; 53(6):1361-71. PubMed ID: 22998777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO-mismatched transfusions are not over-represented in febrile non-haemolytic transfusion reactions to platelets.
    Yazer MH; Raval JS; Triulzi DJ; Blumberg N
    Vox Sang; 2012 Feb; 102(2):175-7. PubMed ID: 21781126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet and TRALI: From blood component to organism.
    Tariket S; Sut C; Hamzeh-Cognasse H; Laradi S; Garraud O; Cognasse F
    Transfus Clin Biol; 2018 Sep; 25(3):204-209. PubMed ID: 29631963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet transfusion therapy in sub-Saharan Africa: bacterial contamination, recipient characteristics, and acute transfusion reactions.
    Hume HA; Ddungu H; Angom R; Baluku H; Kajumbula H; Kyeyune-Byabazaire D; Orem J; Ramirez-Arcos S; Tobian AA
    Transfusion; 2016 Aug; 56(8):1951-9. PubMed ID: 27079627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of complications after blood components' transfusions.
    Timler D; Klepaczka J; Kasielska-Trojan A; Bogusiak K
    Pol Przegl Chir; 2015 Apr; 87(4):166-73. PubMed ID: 26146115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing adverse reactions in pediatric transfusions using washed platelet concentrate.
    Yanagisawa R
    Pediatr Int; 2021 Apr; 63(4):391-403. PubMed ID: 33290634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of transfusion incident reports filed at 15 blood transfusion centers and health facilities during 17 months. Groupe Receveurs de laSFTS].
    Waller C; Vicariot M; Gunzberger H
    Transfus Clin Biol; 1997 Dec; 4(6):541-8. PubMed ID: 9527419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors related to allergic transfusion reactions and febrile non-haemolytic transfusion reactions in children.
    Yanagisawa R; Shimodaira S; Sakashita K; Hidaka Y; Kojima S; Nishijima F; Hidaka E; Shiohara M; Nakamura T
    Vox Sang; 2016 May; 110(4):376-84. PubMed ID: 26808840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet transfusion therapy.
    Slichter SJ
    Hematol Oncol Clin North Am; 2007 Aug; 21(4):697-729, vii. PubMed ID: 17666286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactive lipids as biomarkers of adverse reactions associated with apheresis platelet concentrate transfusion.
    Duchez AC; Fauteux-Daniel S; Sut C; Ebermeyer T; Heestermans M; Arthaud CA; Eyraud MA; Prier A; Audoux E; Bertrand-Michel J; Payrastre B; Garraud O; Boilard E; Hamzeh-Cognasse H; Cognasse F
    Front Immunol; 2023; 14():1031968. PubMed ID: 37138863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory mediators in platelet transfusion reactions.
    Morrell CN
    Hematology Am Soc Hematol Educ Program; 2011; 2011():470-4. PubMed ID: 22160076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased complement activation during platelet storage.
    Chen J; Losos M; Yang S; Li J; Wu H; Cataland S
    Transfusion; 2017 Sep; 57(9):2182-2188. PubMed ID: 28671303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet soluble CD40-ligand level is associated with transfusion adverse reactions in a mixed threshold-and-hit model.
    Cognasse F; Sut C; Fromont E; Laradi S; Hamzeh-Cognasse H; Garraud O
    Blood; 2017 Sep; 130(11):1380-1383. PubMed ID: 28720587
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.